Evidence map›Paper›PMID 41423661›Full record

ArticleScientific reports2025

Identification of new interactors of eIF3f by endogenous proximity-dependent biotin labelling in human muscle cells.

Lionel Tintignac, Nitish Mittal, Shahidul Alam, Meric Ataman, Yusuf I Ertuna, Thomas Bock, Beat Erne, Mihaela Zavolan, Michael Sinnreich

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lionel Tintignac *Neuromuscular Research Group, Departments of Neurology and Biomedicine, University and University Hospital Basel, Basel, Switzerland. lionel.tintignac@unibas.ch.
Nitish Mittal *Biozentrum, University of Basel, Basel, Switzerland. nitish.mittal@unibas.ch.
Shahidul AlamNeuromuscular Research Group, Departments of Neurology and Biomedicine, University and University Hospital Basel, Basel, Switzerland.
Meric AtamanBiozentrum, University of Basel, Basel, Switzerland.
Yusuf I ErtunaNeuromuscular Research Group, Departments of Neurology and Biomedicine, University and University Hospital Basel, Basel, Switzerland.
Thomas BockBiozentrum, University of Basel, Basel, Switzerland.
Beat ErneNeuromuscular Research Group, Departments of Neurology and Biomedicine, University and University Hospital Basel, Basel, Switzerland.
Mihaela ZavolanBiozentrum, University of Basel, Basel, Switzerland.
Michael SinnreichNeuromuscular Research Group, Departments of Neurology and Biomedicine, University and University Hospital Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of protein synthesis is central to maintaining skeletal muscle integrity and its understanding is important for the treatment of muscular and neuromuscular pathologies. The eIF3f subunit of the translation initiation factor eIF3 has a key role, as it stands at the crossroad between protein-synthesis-associated hypertrophy and MAFbx/atrogin-1-dependent atrophy. To decipher the molecular mechanisms underpinning the role of eIF3f in regulating muscle mass, we established a cellular model that enables interrogation of eIF3f functionality via identification of proximal interactors. Using CRISPR-Cas9 molecular scissors, we generated single cell clones of immortalised human muscle cells expressing eIF3f fused to the BirA biotin ligase (eIF3f-BioID1 chimera) from the endogenous EIF3F locus. Biotinylated proteins, representing interactors of eIF3f in nanometer range distance, were identified by streptavidin pull-downs and mass spectrometry. In both proliferating and differentiated muscle cells, the eIF3f-BioID1 chimera co-sedimented with ribosomal complexes in polysome profiles and interacted mainly with components of the eIF3 complex, and with the eIF4E, eIF4G, and eIF5 initiation factors. Surprisingly, we identified several nucleus-localised interactors of eIF3f, and the immunofluorescence analyses revealed a previously unknown nuclear localization of eIF3f in both myoblasts and myotubes. We also identified novel cytoplasmic partners of eIF3f, responsible for the maintenance of skeletal muscle ultrastructure (sarcomeric/Z-disc (SYNPO2) bound proteins) and proteins of the lysosomal compartment (LAMP1). The established tagging system should be useful to further advance studies of eIF3f function in hypertrophic and atrophic conditions in skeletal muscle.

Indexed as

BiotinEukaryotic Initiation Factor-3Muscle CellsBiotinylationCell LineHumansMuscle, SkeletalProtein BindingBiotinEIF3F protein, humanEukaryotic Initiation Factor-3

Identifiers

PMID41423661
PMCPMC12824170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.